AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2024
Jul 23, 2024
32093_dirs_2024-07-22_d810365e-36c1-4b11-830b-d0a081def136.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2024-07-19
Reporting Person: Barrett Burke Thomas (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-19 | Common Stock | X | 543 | $11 | Acquired | 11629 | Direct |
| 2024-07-19 | Common Stock | X | 543 | $11 | Acquired | 12172 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-19 | Warrant (right to buy) | $11 | X | 543 | Disposed | 2029-07-03 | Common Stock (543) | Direct |
| 2024-07-19 | Warrant (right to buy) | $11 | X | 543 | Disposed | 2029-07-03 | Common Stock (543) | Direct |
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Capital/Financing Update
2026
May 6
Earnings Release
2026
May 4
Investor Presentation
2026
Apr 27
Investor Presentation
2026
Apr 16
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 7
Board/Management Information
2026
Mar 27
Regulatory Filings
2026
Mar 17